- Open Access
MiR-204 regulates cardiomyocyte autophagy induced by ischemia-reperfusion through LC3-II
- Jian Xiao†1,
- Xiaoyan Zhu†2,
- Bin He†3,
- Yufeng Zhang1,
- Bo Kang1,
- Zhinong Wang1Email author and
- Xin Ni2Email author
© Xiao et al; licensee BioMed Central Ltd. 2011
Received: 16 January 2011
Accepted: 1 June 2011
Published: 1 June 2011
Autophagy plays a significant role in myocardial ischemia-reperfusion (IR) injury. So it is important to inhibit autophagy to protect cardiomyocytes besides anti-apoptosis. MiRNA has been demonstrated to protect cardiomyocytes against apoptosis during IR, while whether it has anti-autophagy effect has not been known. The aim of this study was to investigate whether miR-204 regulated autophagy by regulating LC3-II protein, which is the marker of autophagosome during myocardial IR injury.
Adult SD rats were randomized to Control and IR groups. IR group was treated with 30 min ischemia by ligating the left anterior descending coronary artery, followed by 2 h reperfusion by loosing the ligation. The expression of miR-204 was measured by RT-PCR, and LC3 protein was measured by western-blot.
We found that IR induced cardiomyocytes autophagy, together with down-regulation of miR-204 and up-regulation of LC3-II protein. And, we have found that LC3-II protein was regulated by miR-204, using the method of transferring miR-204 mimic or AMO-204 into the cardiomyocytes, before.
These studies provided evidence that miR-204 played an important role in regulating autophagy through LC3-IIprotein during IR.
Autophagy is a type of programmed cell death. It has been suggested to be essential for cell homeostasis [1–3]. It can determine the cell survival together with apoptosis and necrosis [4, 5]. Autophagy level is very low in physiological conditions, and is upregulated in many pathophysiological processes [6, 7]. Because cardiomyocytes are terminally differentiated cells which can not divide again, suitable autophagy is essential for the maintenance of cardiomyocytes homeostasis. So, autophagocytic deficiencies or excess is associated with many cardiac pathologies, such as ischemia, IR, and heart failure [8, 9]. It has been found that autophagy increased after IR , but it is still unclear whether autophagy protects the heart against IR injury or contributes to cell death. It seems that modest levels of autophagy appear to be protective. While high levels of autophagy may cause self-digestion and promote cell death .
Autophagy is regulated by many autophagy related genes (Atgs) which are involved in autophagosome formation . Among these Atgs, LC3 (microtubule-associated protein 1 light chain 3, Atg8) is localized on the autophagosome membrane. So LC3 is essential for the formation of autophagosome . During the formation of autophagosome, the soluble form of LC3 (LC3-I) is convered to the autophagic vesicle-associated form (LC3-II), which is an important marker of autophagy . So it is possible to control the process of autophagy by up-regulating or down-regulating LC3, and the molecular mechanism for this effect has yet to be elucidated.
As we know, microRNAs (miRNAs or miRs), which negatively regulate protein expression in diverse biological and pathological processes, have been demonstrated to play an important role in myocardial injury [15–17]. It has been observed that many miRNAs regulate cell apoptosis, such as miR-1, miR-133, miR-199, miR-208, miR-320, miR-21, and miR-204, etc [18–23]. However, it is well known that when apoptosis is blocked, the cells, which preferentially die by apoptosis, may die by autophagy . So it will be beneficial for cell survival if autophagy is inhibited together with apoptosis. We found that miR-204, which has anti-apoptosis effect, may also regulate LC3 expresion through the 9 complementary bases, according the bioinformatics of Targetscan.
So the present study was undertaken to see whether miR-204 was dysregulated by ischemia-reperfusion (IR), and if it may inhibit autophagy during hypoxia-reoxygenation by regulating LC3.
Material and methods
All animal experiments were approved by the Animal Research Ethics Committee of the Second Military Medical University, Shanghai, China. The investigation conformed with the guide for the care and use of laboratory animals published by the US National Institutes of Health.
IR model and experimental protocols
SD rats (250-300 g) were anesthetized with 10% chloral hydrate (300 mg/kg, i.p.) before endotracheal intubation. IR was induced by ligating the left anterior descending artery (LAD) for 30 min, followed by loosening the ligature for 120 min. Successful ligation of LAD was evidenced by immediate regional cyanosis in the anterior ventricular wall and the apex of the heart with color change greater than 40% of the left ventricle (LV) and confirmed by electrocardiography(ECG).
Twenty rats were equally randomly assigned into two groups: Control group (Con group, n = 10), where the rats underwent thoracotomy without ligation; IR group (n = 10), where the rats were treated with ischemia for 30 min and reperfusion for 120 min.
Infarct size measurement
Infarct size of the myocardium was measured as previously described. Infarct area (INF) and area at risk (AAR) were determined by computerized planimetry. The percentage of INF/AAR was calculated.
Blood serum was collected after 180 min reperfusion for determination of lactate dehydrogenase (LDH).
Quantitative real-time RT-PCR of miR-204
Primers used for quantitative real-time RT-PCR
Protein concentration was determined with BCA protein assay kit according the manufacturer's protocol. Equal amounts of protein (60 ug) from the cardiomyocytes were subjected to Western-blotting analysis to evaluate LC3 expression with ECL detection kit (Amersham Biosciences, Piscataway, NJ). LC3 immunoreactivity was detected using a rabbit antiserum specific for rat Beclin1 protein (Sigma, USA) as primary antibodies. Detection of antigen-antibody complex formation was performed with horseradish peroxidase (HRP)-conjugated goat anti-rabbit secondary antibody. The LC3 concentrations were normalized with β-actin.
Quantitative data are presented as mean ± standard error. Statistical significance was determined using T test or one-way ANOVA. P < 0.05 was considered statistically significant.
Myocardium injury was induced by IR
IR decreased the expression of miR-204
IR up-regulated the protein level of LC3-II
In recent years, autophagy has attracted great interest because it was involved in many physiological processes. If autophagy destroys the cytosol and organelles beyond a certain threshold, autophagic cell death will occur . Autophagy was detrimental during reperfusion although it protected the cardiomyocytes during ischemia, which has been demonstrated by Matsui and his collaborators . It has been reported that autophagy contributed to cell death when apoptosis is inhibited, and sometimes the early stages of autophagy were required for apoptosis . LC3-II was the marker of autophagosome, instead of LC3-I. So the ratio of LC3-II/LC3-I could stand for the level of autophagy. In our study, we found that IR up-regulated the protein expression of LC3-II together with increasing the ratio of autophagy cell. So it would be beneficial for the revascularized hearts, to find a method of regulating LC3-II expression.
MiRNA is a group of small, non-coding RNAs which regulates gene expression in a sequence-dependent manner. They are endogenous regulators of gene expression, and have been demonstrated to be involved in cardiac IR injury. According to the bioinformatics of Targetscan, miR-204, which has anti-apoptosis effect , may regulate the expression of LC3-II.
In our study, it was found that IR could down-regulate miR-204 together with up-regulated LC3-II protein. When miR-204 mimic was transferred into cardiomyocytes, LC3-II protein was attenuated, and LC3-II protein was up-regulated by AMO-204 which was concentration- dependented as other miRNAs . But LC3-I was not regulated by miR-204, as the previous study . These results demonstrated that miR-204 may regulate cardiomyocytes autophagy through LC3-II during IR injury.
Our results demonstrated that miR-204 played an important role by regulating LC3-II protein during IR. So it became possible to control the autophagy under a beneficial threshold by regulating miR-204 expression, for protecting the cardiomyocyte against IR injury. But it is still unknown how did IR regulated the expression of miR-204, and this will be our next work.
This work was supported by the National Nature Science Foundation of China (No.30901470, No.30800375 and No.30700157).
- Melendez A, Talloczy Z, Seaman M, Eskelinen EL, Hall DH, Levine B: Autophagy genes are essential for dauer development and life-span extension in c. Elegans. Science. 2003, 301: 1387-1391. 10.1126/science.1087782.View ArticlePubMedGoogle Scholar
- Stromhaug PE, Klionsky DJ: Approaching the molecular mechanism of autophagy. Traffic. 2001, 2: 524-531. 10.1034/j.1600-0854.2001.20802.x.View ArticlePubMedGoogle Scholar
- Otto GP, Wu MY, Kazgan N, Anderson OR, Kessin RH: Macroautophagy is required for multicellular development of the social amoeba dictyostelium discoideum. J Biol Chem. 2003, 278: 17636-17645. 10.1074/jbc.M212467200.View ArticlePubMedGoogle Scholar
- Yan L, Vatner DE, Kim SJ, Ge H, Masurekar M, Massover WH, Yang G, Matsui Y, Sadoshima J, Vatner SF: Autophagy in chronically ischemic myocardium. Proc Natl Acad Sci USA. 2005, 102: 13807-13812. 10.1073/pnas.0506843102.PubMed CentralView ArticlePubMedGoogle Scholar
- Zhang Y, Sun Q, He B, Xiao J, Wang Z, Sun X: Anti-inflammatory effect of hydrogen-rich saline in a rat model of regional myocardial ischemia and reperfusion. Int J Cardiol. 2010Google Scholar
- Gustafsson AB, Gottlieb RA: Recycle or die: The role of autophagy in cardioprotection. J Mol Cell Cardiol. 2008, 44: 654-661. 10.1016/j.yjmcc.2008.01.010.PubMed CentralView ArticlePubMedGoogle Scholar
- Zhang JL, Lu JK, Chen D, Cai Q, Li TX, Wu LS, Wu XS: Myocardial autophagy variation during acute myocardial infarction in rats: The effects of carvedilol. Chin Med J (Engl). 2009, 122: 2372-2379.Google Scholar
- Cuervo AM: Autophagy: Many paths to the same end. Mol Cell Biochem. 2004, 263: 55-72.View ArticlePubMedGoogle Scholar
- Hein S, Arnon E, Kostin S, Schonburg M, Elsasser A, Polyakova V, Bauer EP, Klovekorn WP, Schaper J: Progression from compensated hypertrophy to failure in the pressure-overloaded human heart: Structural deterioration and compensatory mechanisms. Circulation. 2003, 107: 984-991. 10.1161/01.CIR.0000051865.66123.B7.View ArticlePubMedGoogle Scholar
- Decker RS, Wildenthal K: Lysosomal alterations in hypoxic and reoxygenated hearts. I. Ultrastructural and cytochemical changes. Am J Pathol. 1980, 98: 425-444.PubMed CentralPubMedGoogle Scholar
- Sadoshima J: The role of autophagy during ischemia/reperfusion. Autophagy. 2008, 4: 402-403.View ArticlePubMedGoogle Scholar
- Nishida K, Kyoi S, Yamaguchi O, Sadoshima J, Otsu K: The role of autophagy in the heart. Cell Death Differ. 2009, 16: 31-38. 10.1038/cdd.2008.163.View ArticlePubMedGoogle Scholar
- Kabeya Y, Mizushima N, Ueno T, Yamamoto A, Kirisako T, Noda T, Kominami E, Ohsumi Y, Yoshimori T: Lc3, a mammalian homologue of yeast apg8p, is localized in autophagosome membranes after processing. EMBO J. 2000, 19: 5720-5728. 10.1093/emboj/19.21.5720.PubMed CentralView ArticlePubMedGoogle Scholar
- Asanuma K, Tanida I, Shirato I, Ueno T, Takahara H, Nishitani T, Kominami E, Tomino Y: Map-lc3, a promising autophagosomal marker, is processed during the differentiation and recovery of podocytes from pan nephrosis. Faseb J. 2003, 17: 1165-1167.PubMedGoogle Scholar
- Huang ZP, Neppl RL, Wang DZ: Micrornas in cardiac remodeling and disease. J Cardiovasc Transl Res. 2010, 3: 212-218. 10.1007/s12265-010-9165-y.View ArticlePubMedGoogle Scholar
- Ye Y, Hu Z, Lin Y, Zhang C, Perez-Polo JR: Downregulation of microrna-29 by antisense inhibitors and a ppar-gamma agonist protects against myocardial ischaemia-reperfusion injury. Cardiovasc Res. 2010, 87: 535-544. 10.1093/cvr/cvq053.View ArticlePubMedGoogle Scholar
- Roy S, Khanna S, Hussain SR, Biswas S, Azad A, Rink C, Gnyawali S, Shilo S, Nuovo GJ, Sen CK: Microrna expression in response to murine myocardial infarction: Mir-21 regulates fibroblast metalloprotease-2 via phosphatase and tensin homologue. Cardiovasc Res. 2009, 82: 21-29. 10.1093/cvr/cvp015.PubMed CentralView ArticlePubMedGoogle Scholar
- Pan ZW, Lu YJ, Yang BF: Micrornas: A novel class of potential therapeutic targets for cardiovascular diseases. Acta Pharmacol Sin. 2010, 31: 1-9. 10.1038/aps.2009.175.PubMed CentralView ArticlePubMedGoogle Scholar
- Bostjancic E, Zidar N, Stajer D, Glavac D: Micrornas mir-1, mir-133a, mir-133b and mir-208 are dysregulated in human myocardial infarction. Cardiology. 2010, 115: 163-169. 10.1159/000268088.View ArticlePubMedGoogle Scholar
- Xu C, Lu Y, Pan Z, Chu W, Luo X, Lin H, Xiao J, Shan H, Wang Z, Yang B: The muscle-specific micrornas mir-1 and mir-133 produce opposing effects on apoptosis by targeting hsp60, hsp70 and caspase-9 in cardiomyocytes. J Cell Sci. 2007, 120: 3045-3052. 10.1242/jcs.010728.View ArticlePubMedGoogle Scholar
- Ren XP, Wu J, Wang X, Sartor MA, Qian J, Jones K, Nicolaou P, Pritchard TJ, Fan GC: Microrna-320 is involved in the regulation of cardiac ischemia/reperfusion injury by targeting heat-shock protein 20. Circulation. 2009, 119: 2357-2366. 10.1161/CIRCULATIONAHA.108.814145.PubMed CentralView ArticlePubMedGoogle Scholar
- Rane S, He M, Sayed D, Vashistha H, Malhotra A, Sadoshima J, Vatner DE, Vatner SF, Abdellatif M: Downregulation of mir-199a derepresses hypoxia-inducible factor-1alpha and sirtuin 1 and recapitulates hypoxia preconditioning in cardiac myocytes. Circ Res. 2009, 104: 879-886. 10.1161/CIRCRESAHA.108.193102.PubMed CentralView ArticlePubMedGoogle Scholar
- Yang BF, Lu YJ, Wang ZG: Micrornas and apoptosis: Implications in the molecular therapy of human disease. Clin Exp Pharmacol Physiol. 2009, 36: 951-960. 10.1111/j.1440-1681.2009.05245.x.View ArticlePubMedGoogle Scholar
- Nishida K, Yamaguchi O, Otsu K: Crosstalk between autophagy and apoptosis in heart disease. Circ Res. 2008, 103: 343-351. 10.1161/CIRCRESAHA.108.175448.View ArticlePubMedGoogle Scholar
- Rothermel BA, Hill JA: Autophagy in load-induced heart disease. Circ Res. 2008, 103: 1363-1369. 10.1161/CIRCRESAHA.108.186551.PubMed CentralView ArticlePubMedGoogle Scholar
- Matsui Y, Takagi H, Qu X, Abdellatif M, Sakoda H, Asano T, Levine B, Sadoshima J: Distinct roles of autophagy in the heart during ischemia and reperfusion: Roles of amp-activated protein kinase and beclin 1 in mediating autophagy. Circ Res. 2007, 100: 914-922. 10.1161/01.RES.0000261924.76669.36.View ArticlePubMedGoogle Scholar
- He B, Xiao J, Ren AJ, Zhang YF, Zhang H, Chen M, Xie B, Gao XG, Wang YW: Role of mir-1 and mir-133a in myocardial ischemic postconditioning. J Biomed Sci. 2011, 18: 22-10.1186/1423-0127-18-22.PubMed CentralView ArticlePubMedGoogle Scholar
- Jian X, Xiao-yan Z, Bin H, Yu-feng Z, Bo K, Zhi-nong W, Xin N: MiR-204 regulate cardiomyocyte autophagy induced by hypoxia-reoxygenation through LC3-II. Int J Cardiol. 2011, 148 (1): 110-2. 10.1016/j.ijcard.2011.01.029.View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.